Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ASX vs GSK✓SelectedUSD · GSKASX vs GSK performance historyLatest closeAs of-7.74%11/16
Stock and ETF performance explorer

ASX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+878.8%
GSK return
+107.3%
Excess return
+771.6%
Maximum drawdown
-52.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.7%-0.1%-7.7%-7.7%
7D-4.5%-1.3%-3.2%-4.2%
30D-17.0%+2.7%-19.8%-17.9%
3M-17.0%+2.7%-19.8%-18.3%
6M-2.0%+3.3%-5.3%-4.6%
YTD+105.8%+6.5%+99.3%+97.3%
1Y+126.8%+10.7%+116.1%+114.2%
3Y+315.1%+64.4%+250.7%+223.2%
5Y+437.9%+46.7%+391.2%+332.2%
10Y+878.8%+109.4%+769.5%+552.7%
All+878.8%+107.3%+771.6%+552.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling